참고문헌
- Rodan, G.A., Martin, T.J. Therapeutic approaches to bone diseases. Science 289: 1508-1514, 2000. https://doi.org/10.1126/science.289.5484.1508
- Boyle, W.J., Simonet, W.S., Lacey, D.L. Osteoclast differentiation and activation. Nature 423: 337-342, 2003. https://doi.org/10.1038/nature01658
- Teitelbaum, S.L., Ross, F.P. Genetic regulation of osteoclast development and function. Nat Rev Genet 3: 638-649, 2003.
- Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7: 292-304, 2007. https://doi.org/10.1038/nri2062
- Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995. https://doi.org/10.1126/science.7878464
- Saudou, F., Finkbeiner, S., Devys, D., Greenberg, M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55-66, 1998. https://doi.org/10.1016/S0092-8674(00)81782-1
- Salvesen, G.S. and Dixit, V.M. Caspases: intracellular signaling by proteolysis. Cell 91: 443-446, 1997. https://doi.org/10.1016/S0092-8674(00)80430-4
- Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S. and Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997. https://doi.org/10.1016/S0092-8674(00)80434-1
- Lindsten, T., Ross, A.J., King, A., Zong, W.X., Rathmell, J.C., Shiels, H.A. et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 6: 1389-1399, 2000. https://doi.org/10.1016/S1097-2765(00)00136-2
- Jiang, X., Wang, X. Cytochrome c-mediated apoptosis. Annu Rev Biochem 73: 87-106, 2004. https://doi.org/10.1146/annurev.biochem.73.011303.073706
- Strasser, A., O'Connor, L. and Dixit, V.M. Apoptosis signaling. Annu Rev Biochem 69: 217-245, 2000. https://doi.org/10.1146/annurev.biochem.69.1.217
- Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933, 2001.
- Wang, Z.B., Liu, Y.Q. and Cui, Y.F. Pathways to caspase activation. Cell Biol Int 29: 489-496, 2007.
- Goel, A., Kunnumakkara, A.B., Aggarwal, B.B. Curcumin as "Curecumin": From kitchen to clinic. Biochem Pharmacol 75: 787-809, 2008. https://doi.org/10.1016/j.bcp.2007.08.016
- Bharti, A.C., Takada, Y., Aggarwal, B.B. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol 172: 5940-5947, 2004. https://doi.org/10.4049/jimmunol.172.10.5940
- Kwak, H.B., Lee, S.W., Li, Y.J., Kim, Y.A., Han, S.Y., Jhon, G.J. et al. Inhibition of osteoclast differentiation and bone resorption by a novel lysophosphatidylcholine derivative. SCOH Biochem Pharmacol 67: 1239-1248, 2004. https://doi.org/10.1016/j.bcp.2003.10.032
- Lee, S.E., Chung, W.J., Kwak, H.B., Chung, C.H., Kwack, K.B., Lee, Z.H. and Kim, H.H. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem 276: 49343-49349, 2001. https://doi.org/10.1074/jbc.M103642200
- Vaananen, H.K., Zhao, H., Mulari, M. and Halleen, J.M. The cell biology of osteoclast function. J Cell Sci 113: 377-381, 2000.
- Tanaka, S., Miyazaki, T., Fukuda, A., Akiyama, T., Kadono, Y., Wakeyama, H., Kono, S., Hoshikawa, S., Nakamura, M., Ohshima, Y., Hikita, A., Nakamura, I. and Nakamura, K. Molecular mechanism of the life and death of the osteoclast. Ann N Y Acad Sci 1068: 180-186, 2006. https://doi.org/10.1196/annals.1346.020
- Glantschnig, H., Fisher, J.E., Wesolowski, G., Rodan, G.A., Reszka, A.A. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell death Differ 10: 1165-1177, 2003. https://doi.org/10.1038/sj.cdd.4401285
- Akiyama, T., Bouillet, P., Miyazaki, T., Kadono, Y., Chikuda, H., Chung, U.I., Fukuda, A., Hikita, A., Seto, H., Okada, T., Inaba, T., Sanjay, A., Baron, R., Kawaguchi, H., Oda, H., Nakamura, K., Strasser, A. and Tanaka, S. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J 22: 6653-6664, 2003. https://doi.org/10.1093/emboj/cdg635
- Liu, W., Wang, S., Wei, S., Sun, L., Feng, X. Receptor activator of NF-kappaB (RANK) cytoplasmic motif, 369PFQEP373, plays a predominant role in osteoclast survival in part by activating Akt/PKB and its downstream effector AFX/FOXO4. J Biol Chem 280: 43064-43072, 2005. https://doi.org/10.1074/jbc.M509006200
- Karsdal, M.A., Henriksen, K., Arnold, M., Christiansen, C. Calcitonin a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality. BioDrugs 22(3):137-144, 2008. https://doi.org/10.2165/00063030-200822030-00001
- Bond, M., Fabunmi, R.P., Baker, A.H. and Newby, A.C. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappaB. FEBS Lett 435: 29-34, 1998. https://doi.org/10.1016/S0014-5793(98)01034-5
- Kamolmatyakul, S., Chen, W., Yang, S., Abe, Y., Moroi, R., Ashique, A.M. and Li YP: IL-1alpha stimulates cathepsin K expression in osteoclasts via the tyrosine kinase-NF-kappaB pathway. J Dent Res 83: 791-796, 2004. https://doi.org/10.1177/154405910408301011
- Singh, S., Aggarwal, B.B. Activation of transcription factor NF-kappaB is suppressed by curcumin (diferuloylmethane). J Biol Chem 270: 24995, 1995. https://doi.org/10.1074/jbc.270.42.24995